INTRODUCTION AND OBJECTIVES: Balloon dilation with fluoroscopic guidance when gaining percutaneous renal access is generally regarded as the safest technique in western countries. However, a major drawback of fluoroscopy is the radiation. Herein, we introduce the safety and effectiveness of ultrasound monitored balloon dilation in the establishment of percutaneous renal access, based on our experience.
METHODS: A retrospective study was performed of patients who underwent percutaneous nephrolithotomy (PCNL) by using ultrasound monitored balloon dilation in our center from December 2014 to May 2016. Data of the patients were analyzed, such as age, sex, stone burden, operative time, operation success, and postoperative findings. The severity of surgical complication was determined according to the Modified Clavien Classification System (MCCS).
RESULTS: 135 patients (69 male and 66 female) with a mean age of 51.6 years (range 34-74 years) were included in this study. Mean size of the largest stone diameter was 36.3mm (range 22.1-48.9mm). A total of 169 percutaneous renal tracts were gained in 142 kidneys. Successful tracts gained by balloon dilation to the collecting system was 94.7% (160/169). All procedures were successfully completed with no major complications during operation. Mean operative duration was 67min (range 51-148min). Mean temperature and mean postoperative hemoglobin drop on the 1st postoperative day were 37.5? (range 36.5-39.6?) and 1.2g/dl (range 0.1-3.2g/dl), respectively. Clavien I complications were noted in 50 cases (transient hematuria in 22 patients, fever in 28 patients), while Clavien II complications were noted in 2 cases (hematuria in 2 patients requiring pharmacological treatment). No major complications (Clavien III-V) occurred. The stone-free rate of PCNL was 82.96% (112/135).
CONCLUSIONS: Our experience demonstrates that real time whole course monitored ultrasound guided percutaneous renal access establishment using balloon dilation was safe and efficient because of its high stone-free rate and low operative time, compared to literatures. It could help to avoid exposition to radiation, not increase the risks of infection, bleeding and postoperative complications. Patients with a hydronephrotic collecting system or target calyx are more suitable for this procedure.
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MP75-16 SUPRACOSTAL ACCESS TUBELESS PERCUTANEOUS NEPHROLITHOTOMY: MINIMIZING COMPLICATIONS
Michael Sourial*, Nathaly Francois, Hiroko Miyagi, Geoffrey Box, Bodo Knudsen, Columbus, OH INTRODUCTION AND OBJECTIVES: Supracostal access in percutaneous nephrolithotomy (PCNL) may be avoided due to concern for thoracic complications. The objective of the study is to report the safety and efficacy of supracostal access utilizing a tubeless (stent only) PCNL technique.
METHODS: From July 2010 to Oct 2016, 70 patients (76 renal units) underwent a supracostal access tubeless PCNL. The study is a retrospective review of their perioperative and postoperative outcomes. All patients underwent a non-contrast CT prior to the surgery. No nephrostomy tubes were left and all patients had a 7F ureteral stent and Foley catheter placed. The nephrostomy sheath was removed with the patient held in expiration, similar to a chest tube, and the incision closed.
RESULTS: Median patient age was 62 years. Median BMI and ASA score was 32.9 kg/m2 and 3, respectively. The median stone size was 20 x 21 mm, and 13 patients had complete staghorn stones. The upper calyx was the site of access in 50 cases. The access was above the 12th and 11th rib in 57 and 12 cases, respectively. The median length of hospital stay was 30 hours. Postoperatively, 48 (63%) patients had no residual fragments (<2 mm) on postoperative imaging. 8 patients underwent an ancillary procedure to clear residual stones (7 URS and 1 ESWL), with an additional 6 patients becoming stone-free after this procedure. Thoracic complications occurred in 2 (2.6%) patients: 1 small pneumothorax that resolved with conservative management, and 1 symptomatic ipsilateral pleural effusion requiring thoracocentesis. Other complications occurred in 9 patients (11.8%) which included bleeding requiring transfusion (1), fever (4), urinary retention (2), and syncope (2).
CONCLUSIONS: Compared to historical controls, our approach to upper tract PCNL utilizing a nephrostomy tube free approach resulted in an overall low thoracic complication rate and facilitated hospital discharge. METHODS: Retrospective cohort study of patients who underwent percutaneous nephrolithotomy at our institution between October 2012 and October 2013 when ESR and CRP levels were part of our standard pre-operative order set. The primary endpoint was the development of SIRS postoperatively; defined as having 2 of the following: temperature >38C or <36C, heart rate >90 beats per minute, respiratory rate >20 breaths per minute or WBC count >12,000 cells/uL or <4000 cells/uL. Multivariable logistic regression was used to evaluate the association between ESR, CRP and the development of SIRS while controlling for potential confounders. Receiver operating characteristics curves were used to evaluate the discriminative ability of the test and identify the optimal cut-offs which maximized sensitivity and specificity.
Source of Funding: None
RESULTS: Among the 107 PCNLs performed during the study period, 35 (33%) of patients had evidence of SIRS during the post-operative stay. Patients who experienced SIRS had a longer operative time (99 min vs. 85 min, p ¼ 0.016), were more likely to have been transferred to the intensive care unit (ICU) (15% vs. 0%, p ¼ 0.002) and experience a longer length of stay (median 2 days vs. 1 day, p < 0.001). On multivariable analysis controlling for operative time and the presence of a positive pre-operative urine culture, both ESR (odds ratio [OR] 1.32, 95% confidence interval [CI], 1.01-1.72, p ¼ 0.04) and CRP (OR 1.59; 95% CI, 1.07-2.37, p ¼ 0.02) were associated with development of SIRS. Among patients without a positive urine culture, an ESR >6.5 mm/hr (AUC 0.62; 95% CI, 0.52-0.78) had sensitivity, specificity, and negative predictive value of 70.4%, 61.5%, and 80.0% respectively, for development of SIRS. Among all patients, a CRP >0.65 mg/dL (AUC 0.63; 95% CI, 0.51 to 0.74) had sensitivity, specificity, and negative predictive value of 51.4%, 69.4%, 74.6%. The combination of a high ESR and CRP using the previously described thresholds demonstrated a lower sensitivity at 31% and higher specificity at 78%. CONCLUSIONS: A preoperative blood test for ESR and CRP was predictive for the development of SIRS after PCNL. This knowledge could be used to risk-stratify patients and guide duration of antibiotic prophylaxis prior to PCNL, particularly among those without a positive urine culture.
MP75-18 COMPARISON OF COSTS AND OUTCOMES OF PERCUTANEOUS NEPHROLITHOTOMY BASED ON PERCUTANEOUS ACCESS
Rutveej Patel*, Kushan Radadia, Christopher Han, Ephrem Olweny, Sammy Elsamra, New Brunswick, NJ INTRODUCTION AND OBJECTIVES: Establishing access into a kidney is a prerequisite for percutaneous nephrolithotomy (PCNL). Currently, access is urologist-obtained (UOA) or radiologistobtained. Ancillary services like interventional radiology (IR) add significant cost and delay, impacting hospital profit margin.
METHODS: We performed a retrospective review of our institutional database of consecutive PCNLs from 01/2014 to 09/2015. The study subjects were separated by which group established renal access. Patient characteristics and clinical variables including blood loss, change in laboratory parameters, length of stay, and complications were analyzed. Costs and material expenses were also compared. Statistical analysis was performed using chi-square, Fisher 0 s exact test, and t-test. P value < 0.05 was considered significant.
RESULTS: Of the 76 PCNLs, 23 (30%) cases contained a UOA. These were performed by two fellowship-trained endourologists: one who routinely obtains renal access and the other who routinely has initial access by IR. The operative details, post-operative parameters, and length of stay were not significant (Table 1) . No significant differences in overall complications existed between the two groups (p¼0.82). The materials cost for the operating room was higher for a UOA, but not significant (Table 2) . When factoring ancillary service costs, the difference became significant ($1500.13 vs. $2150.90, p ¼ 0.0001). Average total cost was cheaper for a UOA PCNL, $29,997.12 versus $34,299.39, or a savings of $4,302.27. Analysis using specific operating room and IR staff/facilities costs show that there is about a 20-minute buffer before the cost-benefit of establishing a UOA is erased.
CONCLUSIONS: Either method of access is suitable for PCNL and offers no significant advantage to clinical outcomes. However, the use of IR led to a 14% increase in costs.
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